ENHANCING EFFICACY OF T-CELL-MEDIATED IMMUNOTHERAPY BY MODULATING CANCER-ASSOCIATED… Application WO-2022243565-A1 World Intellectual Property Organisation (WIPO) 24 Nov 2022
A CXCR3+ CELL OR CELL PREPARATION FOR USE IN CANCER TREATMENT Application WO-2022152767-A3 World Intellectual Property Organisation (WIPO) 10 Nov 2022
NEW ANTI-MUC1 CARS AND GENE EDITED IMMUNE CELLS FOR SOLID TUMORS CANCER IMMUNOTHERAPY Application WO-2022229412-A1 World Intellectual Property Organisation (WIPO) 03 Nov 2022